Tag: Rare Diseases
Twist Bioscience and MedGenome partner to launch HOPE for Rare Diseases...
Collaboration offers affordable whole exome sequencing for underprivileged patients to improve rare disease diagnosis and treatment in India
Rare Diseases India Foundation forms National Hunter Alliance
The newly formed alliance unites medical experts, government officials, and patient advocates to push for improved care
Health Ministry to set up Technical Expert Group for SMA, budget...
Dr. L Swasticharan, Additional Director General at the Directorate General of Health Services (DGHS), announced these developments at SMArtCon2024
SMArtCon2024: Cure SMA Foundation to host national conference on Spinal Muscular...
Two-day event to focus on building a sustainable ecosystem for SMA and other rare diseases, bringing together patients and medical experts
Rare disease patients write to new health minister, demand sustained funding...
Advocates highlight gaps in the National Policy for Rare Diseases implementation and seek urgent attention to save lives
Alliance & Partnerships for Patient Innovation & Solutions deliberates on shaping...
The conference called for accelerating access to evidence-based care to continue improving outcomes for patients
K J Somaiya Hospital & Research Centre inaugurates Advanced Centre for...
It is a first of its kind facility with state-of-the-art infrastructure
Avesthagen enters into strategic alliance with Wipro over genetic testing portfolio
The company has launched breakthrough genetic testing portfolio for cancers, neurological and rare diseases
Takeda expands India portfolio of rare disease therapies
The company has launched Enzyme Replacement Therapy bouquet for Lysosomal Storage Disorders (LSD), Idursulfase for Hunter Syndrome, Velaglucerase Alpha for Gaucher Disease and Agalsidase Alfa for Fabry Disease..........................
Patient groups hail govt’s move to expedite rare disease policy formation
Union Health Minister, Dr Harsh Vardhan has directed ministry officials to speed up the process of formulating the National Policy for Treatment of Rare Diseases (NPTRD), in consultation with all stakeholders....................